4
Changes in Ownership
Zymeworks Inc. Filed Acc 0000950170-24-003076
Chief Scientific Officer sold 9,799 shares at an average $10.79 ($105,699)
- Chief Scientific Officer acquired 17,166 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Moore Paul Andrew · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-05 | Exercise or conversion : show line 1 in the form | +17,166 | 17,166 | D | ||
| 2024-01-05 | Sale : show line 2 in the form | −7,460 | $10.65 | $79,465 | 9,706 | D |
| 2024-01-08 | Sale : show line 3 in the form | −2,339 | $11.22 | $26,233 | 7,367 | D |
| Open-market sales · 9,799 sh · avg $10.79 · $105,699 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-05 | Exercise or conversion : show line 4 in the form Restricted Stock Unit | −17,166 | 34,334 | D |
| 2024-01-05 | Grant or award : show line 5 in the form Stock Option (Right to Buy) | +90,000 | 90,000 | D |
| 2024-01-05 | Grant or award : show line 6 in the form Restricted Stock Unit | +60,000 | 60,000 | D |
Loading xslF345X05/ownership.xml…